Ms Siobhán McArdle:

I will take the question and add to Dr. Keenan's commentary on Ireland's drug deaths and our comparator with other European countries. The type of drug also has an impact. While we do not have the same systems for measuring and collating deaths, we look at the causes of deaths and that also informs us in how to invest the types of treatment or investment that will make a difference. Our budget is approximately €160 million, with additional funding having been provided in the past two years. That has been given to provide a range of interventions, including an increase in the number of drug-support services - the addiction services on the ground - and supports for communities, in addition to the new services for naloxone, the training regime for naloxone and the provision of greater supplies of naloxone to meet the causes of some of the harms in the communities.

I will have to come back to the committee on how we compare with other European countries.